Alpine Associates Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Alpine Associates Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-797,907	Closed	-$11.9M	–	58
2022 Q4	$11.9M	Buy	+797,907	New	+$11M	0.54%	34

Alpine Associates Management's AVEO Position: Q1 2023 in Review

Alpine Associates Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 797,907 shares — an estimated $11.9M sold.

Alpine Associates Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $11.9M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Alpine Associates Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Alpine Associates Management sold 797,907 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $11.9M.
Alpine Associates Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
Alpine Associates Management's AVEO Pharmaceuticals, Inc. position peaked at $11.9M in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Alpine Associates Management's 13F filing for Q1 2023, filed 10 May 2023.